Synergistic innate and adaptive immune response to combination immunotherapy with anti-tumor antigen antibodies and extended serum half-life IL-2.
暂无分享,去创建一个
D. Irvine | M. Yaffe | M. Mihm | G. Dranoff | L. Weiner | K. Wittrup | C. Opel | M. Stephan | R. Surana | K. Moynihan | Monique J. Kauke | A. Angelini | S. Gai | Robert T. Williams | Jacob S Kim | Byron H Kwan | Eric F. Zhu